Picture of Exelixis logo

EXEL — Exelixis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Exelixis Inc expected to post earnings of 21 cents a share - Earnings Preview

* Exelixis Inc  EXEL.OQ   EXEL.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 6 for the
period ending December 31 2023
    * The Alameda California-based  company is expected to
report a
13.3% increase in revenue to $480.175 million from $423.92
million a year ago, according to the mean estimate from 18
analysts, based on LSEG data. (Sales majority is on Total
revenue basis)
    * ​LSEG's mean analyst estimate for Exelixis Inc is for
earnings
of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Exelixis
Inc is
$27.00​, above​ its last closing price of $21.75. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.10        0.10       0.00      Missed  -100
 Jun. 30 2023  0.16        0.16       0.25      Beat    56.3
 Mar. 31 2023  0.15        0.15       0.12      Missed  -19​
 Dec. 31 2022  -0.11       -0.12      -0.09     Beat    26.9
 ​​Sep.        0.18        0.19       0.23      Beat    22.2
 30 2022                                                
 Jun. 30 2022  0.16        0.19       0.22      Beat    17.6​
 Mar. 31 2022  0.14        0.14       0.21      Beat    47.7
 Dec. 31 2021  0.04        0.06       0.29      Beat    375.4
 This summary was machine generated February 2 at 23:08 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Exelixis

See all news